Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

CHMP recommends Trodelvy (sacituzumab govitecan-hziy) to treat triple-negative breast cancer in patients who have not received prior systemic therapy – Gilead Sciences

Written by | 27 May 2026

Gilead Sciences, Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending the marketing… read more.

New benchmarks based on top performers aim for achievable excellence in pediatric emergency care

Written by | 26 May 2026

A large, multi-center study led by Ann & Robert H. Lurie Children’s Hospital of Chicago derived “achievable benchmarks of care” (ABCs) using electronic health record data, which allows… read more.

HPV self-collection boosts cervical cancer screening rates

Written by | 26 May 2026

A Kaiser Permanente study published by NEJM Catalyst Innovations in Care Delivery provides real-world data on a new approach to cervical cancer screening: giving patients the option to skip the… read more.

FDA approves New Guardant360 Liquid CDx, the largest FDA-approved liquid biopsy panel – Guardant Health

Written by | 26 May 2026

Guardant Health announced that the FDA has approved Guardant360 Liquid CDx, advancing blood-based comprehensive genomic testing by integrating genomic and epigenomic insights and helping clinicians make better-informed treatment… read more.

Neutralizing smelly dog breath with plant extracts

Written by | 25 May 2026

Pet owners love their dogs but may not always love the smell of their breath. Because this bad odor can signal oral disease, veterinary clinics will prescribe daily tooth brushing, antibiotics or chemical rinses… read more.

Which patients benefit most from tirzepatide GLP-1 for obesity and OSA?

Written by | 25 May 2026

Tirzepatide GLP-1 medication is known to improve sleep apnea for people with both obstructive sleep apnea (OSA) and obesity, but not all patients benefit equally. Now, new research… read more.

CE mark granted for Elecsys pTau217 blood test for Alzheimer’s pathology detection – Roche

Written by | 25 May 2026

Roche announced that it has received CE Mark for Elecsys pTau217, a blood test developed in collaboration with Eli Lilly and Company and designed to measure the phosphorylated… read more.

National Poll: Only 1 in 3 parents say teen had private time with health provider

Written by | 24 May 2026

While most parents say it’s important for health care providers to speak privately with teens during checkups, far fewer are putting that belief into practice, according to a… read more.

New study reveals best dosage for ADHD medications

Written by | 24 May 2026

Researchers have identified the best dosage for each ADHD medication using data from thousands of people with the condition. A new study published today [14 May] in The Lancet… read more.

Higher dose Wegovy demonstrates nearly 28% weight loss in early responders according to new analyses presented at the European Congress on Obesity – Novo Nordisk

Written by | 24 May 2026

Novo Nordisk is presenting a new sub-analysis from the large clinical trial STEP UP at the European Congress on Obesity (ECO) on 12-15 May in Istanbul, Türkiye, showing… read more.

Trial shows rapid weight loss is much more effective than gradual weight loss in achieving and sustaining clinically meaningful weight loss

Written by | 23 May 2026

New research presented at this year’s European Congress on Obesity (ECO  2026) in Istanbul, Turkey, shows that rapid weight loss (RWL) is much more effective than gradual weight… read more.

No clear link between common antidepressant use in pregnancy and autism or ADHD in children, finds most comprehensive study to date

Written by | 23 May 2026

Current evidence does not support a causal link between the use of almost all antidepressants during pregnancy and an increased risk of neurodevelopmental disorders, including autism and attention-deficit/hyperactivity… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.